About

Why?

The pace of change in healthcare is rapidly accelerating. Medical device innovations contribute to better healthcare in many different ways. For example, enabling less invasive treatments, diagnosing patients earlier, and facilitating self/home-monitoring. However, bringing valuable and relevant innovations to users is challenging.

All too often, however, that promise is hampered by the extremely challenging and time-consuming process of getting market authorization (CE marking). This is partly caused by the complexity of the healthcare market and a lack of clarity about what is required by, for example, regulators, payers, and users.

Ambition

HI-NL's ambition is to evaluate innovations that have the potential to positively impact the design of sustainable healthcare systems. It does so using fit-for-purpose evaluation processes that are applied

• EARLIER: engaging at an early stage all important stakeholders involved in the use, evaluation, decision-making, implementation, reimbursement, and upscaling of innovations.
• FASTER: ensuring a more rapid development process via customization and proven ‘fit-for-innovation’ guidance.
• MORE EFFECTIVE: improving implementation of promising innovations, and terminating, or suggesting substitutions for, non-promising innovations.

HI-NL aims to become the go-to partner in the Netherlands for medical innovations, and a portal towards Europe and the US, whenever support is required for their evaluation and implementation.

HI-NL also aims to create a joint research agenda that prioritizes activities that can best improve the health innovation process. The new European Medical Device Regulation (MDR), which came into force in May 2021, provides us with a valuable opportunity to improve the current evaluation and decision-making process around non-pharmaceutical innovations.

Health Innovation Netherlands (HI-NL) provides guidance to innovators through its HI-NL trajectory.

Visual identity and logo

Health Innovation Netherlands is open and inclusive, with all stakeholders welcomed. By taking part, they provide essential feedback and guidance.

The blue circle with the green arch represents the Round Table – a pivotal element of our services – and also the iris of a human eye. This highlights our belief that both stakeholders and innovators have valuable opinions to share on opportunities for improving patient healthcare.

Different logo elements can move independently while retaining their identity. This symbolizes growth and change. They also form the initials of Health Innovation Netherlands.

Colors are contemporary, conveying a sense of ‘fresh’ and ‘calm’. The blue hints at ‘blueprints’ of products under development, and the vertical line forms a beacon visible from far away – a guiding light for ideas. Together, they form an identity that is responsive to change but also well defined, helping to remove barriers for innovators who want to pitch their ideas and have them evaluated.